Asset Type: Brochures, Imaging, Imaging Core Lab, Radiopharmaceutical 
Therapy & Theranostics

End-to-End Dosimetry for Radiopharmaceutical Development

End-to-End Dosimetry for Radiopharmaceutical Development

End-to-End Dosimetry for Radiopharmaceutical Development

Perceptive is the leading imaging CRO in radiopharmaceuticals, supporting the vast majority of radiopharmaceutical programs from discovery through global clinical trials.

With over 200 dosimetry studies supported, the largest dedicated dosimetry and advanced analytics team in the industry, and deep regulatory expertise, Perceptive provides sponsors the assurance that dose estimates are scientifically rigorous, reproducible, and regulatory aligned.

How Can We Help?

Reach out today and one of our solution experts will be in touch to learn about your specific needs.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
By subscribing, you consent to receive emails from Perceptive. We respect your privacy and you can manage your communication preferences anytime. You can find the Perceptive privacy policy.